Boston-area startup Windgap Medical is going right up against the ubiquitous EpiPen. It’s working on a more streamlined version of the epinephrine auto-injector.
As allergies rise, so does the need for on-the-spot epinephrine treatment. Windgap wants to win a chunk of this fast-growing, $1.3 billion market.
Hey, check out all the engineering jobs. Post your resume today!
